3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR

Baojian Wu1, Sha Li, Dong Dong

  • 1Division of Pharmaceutics, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou, Guangdong 510632, China. bj.wu@hotmail.com

Drug Discovery Today
|January 10, 2013
PubMed

Insights

Constitutive androstane receptor (CAR), pregnane X receptor (PXR), and vitamin D receptor (VDR) are key human proteins. Their 3D structures reveal ligand-binding specificities and activation mechanisms, explaining receptor promiscuity and specificity.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Pharmacology

Background:

  • Nuclear receptors like CAR, PXR, and VDR regulate critical human genes, including those for metabolic enzymes and transporters.
  • The 3D structures of their ligand-binding domains (LBDs) are crucial for understanding how they bind to various molecules and become activated.

Purpose of the Study:

  • To analyze the 3D structures of the ligand-binding domains (LBDs) of CAR, PXR, and VDR.
  • To correlate structural features with known ligand-binding profiles and activation mechanisms.
  • To elucidate the molecular basis for the specificity and promiscuity of these nuclear receptors.

Main Methods:

  • Analysis of existing 3D crystal structures of the ligand-binding domains (LBDs) of CAR, PXR, and VDR.
  • Comparison of the structural characteristics of the ligand-binding sites.
  • Correlation of structural data with published ligand-binding data for each receptor.

Main Results:

  • The ligand-binding site of PXR is characterized as large and flexible.
  • The ligand-binding sites of CAR and VDR are described as compact and rigid, respectively.
  • Observed ligand profiles for CAR, PXR, and VDR generally align with their respective LBD structural features.

Conclusions:

  • The 3D structures of CAR, PXR, and VDR LBDs provide significant insights into their ligand-binding specificities.
  • Structural variations in the ligand-binding sites explain the differential promiscuity and specificity of these receptors.
  • Crystal structures are invaluable tools for understanding nuclear receptor function and drug interactions.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...